Reported 1 day ago
At the 23rd Annual Global Healthcare Conference on September 8, 2025, DENTSPLY SIRONA Inc. (NASDAQ: XRAY) executives presented a refined strategy focusing on structural reforms to enhance decision-making and resource allocation towards R&D and sales. They aim for over 19% margins in fiscal 2025, forecast a $300–400 million cash flow, and anticipate a drop in organic revenue due to tariffs. The company also emphasizes improving customer satisfaction and expanding its direct distribution channels while exploring acquisition opportunities across its four business segments.
Source: YAHOO